Pharma Industry: Improve Your Flexibility To Thrive In A Highly Regulated Manufacturing Environment
By Nero Haralalka
January 9, 2024
It sounds counterintuitive. After all, the whole point of regulations is to put (often rigid) rules into place to govern manufacturing processes and ultimately protect the integrity, efficacy, and safety of regulated products, such as pharmaceuticals and medical devices.
Clearly, this is a critical goal. The problem is that adherence to regulations often creates a mindset among manufacturing leaders that results in a form of tunnel vision and a reluctance to challenge the status quo. Performance improvement opportunities go overlooked. This can end up hamstringing a manufacturer’s ability to pursue process improvements that lead to breakthroughs in performance that enhance both the top and bottom line. And it can jeopardize a manufacturer’s ability to respond to changes and challenges in the industry as they arise
Why is manufacturing flexibility such a challenge for pharmaceutical companies?
Manufacturing flexibility is challenging in pharma because operations are constrained by regulatory requirements, complex validation processes, and batch‑based production. The article explains that while compliance is essential, rigid processes and long changeover times often limit the ability to respond quickly to demand changes, product mix shifts, or supply disruptions. These constraints can leave capacity underutilized and slow the introduction of new or adjusted products.
What operational barriers most limit flexibility in pharmaceutical manufacturing?
The article highlights barriers such as long setup and changeover times, process variability, siloed decision‑making, and weak visibility into true capacity constraints. These issues are often compounded by conservative planning assumptions designed to avoid risk. Over time, this leads to excess buffers, inefficient scheduling, and reduced responsiveness to market or customer needs.
How can pharmaceutical manufacturers improve flexibility without increasing compliance risk?
Pharmaceutical manufacturers can improve flexibility by strengthening execution discipline and process stability. The article emphasizes standard work, improved changeover performance, and disciplined daily management to reduce variability. When processes are well controlled and predictable, manufacturers can safely adjust schedules, product mix, and throughput—improving flexibility while maintaining full regulatory compliance.
Nero Haralalka has extensive experience in lean manufacturing and back office process improvement. He is one of our leading subject matter experts in statistical problem solving.
